GlassScriptPhysician profile
Bridget M Abney
NPI 1245235084
$1,074.58
in general payments reported to CMS, 2019-2025
23 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $186 · 2021: $132 · 2022: $179 · 2023: $112 · 2024: $41.94 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.47 | 2019-2022 | |
| Hologic Sales and Service, LLC | $104.11 | 2019-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
| Bayer Healthcare Pharmaceuticals INC. | $88.43 | 2020-2022 | |
| Exeltis, USA INC. | $71.09 | 2019-2023 | Slynd |
| Agile Therapeutics, INC. | $50.30 | 2021-2023 | Twirla |
| Novo Nordisk INC | $47.23 | 2023-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $44.68 | 2019-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Therapeuticsmd, INC. | $30.74 | 2022 | |
| Astellas Pharma US INC | $29.02 | 2025 | Veozah |
| Genzyme Corporation | $27.46 | 2025 | |
| Olympus America INC. | $25.82 | 2019 | |
| Allergan, INC. | $23.52 | 2019 | |
| Biogen, INC. | $21.48 | 2024 | |
| Organon LLC | $21.38 | 2023-2025 | Nexplanon, Jada System |
| Coopersurgical, INC. | $18.72 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $17.66 | 2025 | Flexitouch Plus, Nimbl |
| Amgen INC. | $17.25 | 2025 | Evenity |
| Boston Scientific Corporation | $16.07 | 2021 | |
| Scynexis, INC. | $15.16 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.11 | 2025 | Caplyta |
| Pfizer INC. | $15.00 | 2023 | |
| Minerva Surgical, INC | $13.33 | 2019 | |
| Mayne Pharma Commercial LLC | $12.55 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Abney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.